Baltimore, MD - July 11, 2022 - Starting Monday July 11th, Accu Testing is proud to join the Maryland State Test to Treat (T2T) program. Patients who test positive on any of our rapid tests can be eligible to receive Pfizer's Paxlovid medication immediately, directly at our testing center. Patients will be screened by a medical provider to ensure eligibility for Paxlovid. If deemed eligible (see here), they will be given a full regimen of Paxlovid. Patients will need to provide medical insurance which will be billed for the medical screening and prescription (Copay may be applicable depending on your plan). T2T is available Sun-Thu from 7pm until 8:30pm only, at the Accu Testing clinic located at 122 Slade Ave. Suite 101 Pikesville, MD 21208.

FAQ:

Can you accept a home-test result or test result from another clinic or test site?

No, under the T2T program, you must be tested onsite at our clinic in order to be eligible.

What are the criteria to be eligible for Paxlovid?

See this link for more details.

If I am not eligible for Paxlovid, do you also offer monoclonal antibody infusions?

Yes, we anticipate starting this onsite as well in the next couple of days. If you need it immediately, our staff will provide you with options to obtain MABS infusions.

Can I be tested anytime during the day?

You can be tested anytime during the day. However, the provider who will review your results and medical history and provide Paxlovid will currently only be available daily (S-TH) from 7pm until 8:30pm.